Intermediate dose methotrexate and sequential L-asparaginase for treatment of refractory acute lymphocytic leukaemia.

Shetty, P A; Kurkure, P A; Dasgupta, A

Shetty, P A; Kurkure, P A; Dasgupta, A.

Indian J Cancer ; 1984 Mar-Apr; 21(1): 45-9

Article in English | IMSEAR | ID: sea-50176

Subject(s)

Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Asparaginase/administration & dosage; Child; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Leukemia, Lymphoid/drug therapy; Male; Methotrexate/administration & dosage

Fulltext

XML

Search on Google

Full text: Available Index: IMSEAR (South-East Asia) Main subject: Asparaginase / Female / Humans / Male / Drug Administration Schedule / Leukemia, Lymphoid / Antineoplastic Combined Chemotherapy Protocols / Child / Methotrexate / Follow-Up Studies Type of study: Observational study / Prognostic study Language: English Journal: Indian J Cancer Year: 1984 Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google